# A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects

> **NCT03363815** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 56 (actual)

## Conditions studied

- Heathy Volunteer

## Interventions

- **DRUG:** CC-90001
- **DRUG:** Omeprazole
- **DRUG:** Midazolam
- **DRUG:** Warfarin
- **DIETARY_SUPPLEMENT:** Vitamin K
- **DRUG:** Rosuvastatin
- **DRUG:** Metformin
- **DRUG:** Digoxin
- **DRUG:** Nintedanib

## Key facts

- **NCT ID:** NCT03363815
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-04
- **Primary completion:** 2018-07-29
- **Final completion:** 2018-07-29
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2019-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03363815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03363815, "A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03363815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*